MOTS-c: The Mitochondrial Peptide Regulating Metabolic Health

MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome itself — a "mitochondrial-derived peptide" with distinct biology from the proteome encoded in nuclear DNA. This article explains what MOTS-c is, what recent preclinical research (2025–2026) reports on metabolism and glucose regulation, and its current regulatory position. Nothing here is medical advice; MOTS-c is not FDA-approved for therapeutic use.

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene. Unlike most cellular proteins, which are transcribed from nuclear DNA and imported into mitochondria, MOTS-c is transcribed directly from mitochondrial DNA and translated within the mitochondrial matrix. This unusual origin gives it a role distinct from other peptides: signaling between the mitochondrial and nuclear genomes to regulate cellular energy metabolism.

Core metabolic mechanism: AMPK and PGC-1α

The primary mechanism by which MOTS-c is studied involves activation of AMP-activated protein kinase (AMPK) and downstream activation of PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha). This axis is central to how cells sense and respond to energy deficit. AMPK, often called the "metabolic master switch," signals low cellular energy and triggers:

• Increased mitochondrial biogenesis via PGC-1α, building more mitochondria to meet energy demand.
• Improved mitochondrial respiration and oxidative phosphorylation efficiency.
• Shift toward fat oxidation, reducing glucose-dependent metabolism.

Recent preclinical findings (2025–2026)

The last year has produced several significant publications in peer-reviewed literature:

• Muscle bioenergetics (March 2026). A study published in Free Radical Biology and Medicine found that MOTS-c administration augmented skeletal muscle mitochondrial bioenergetic performance through both PGC-1α and AMPK signaling pathways, with measurable improvements in ATP production efficiency.
• Pancreatic islet senescence (August 2025). Experimental & Molecular Medicine reported that MOTS-c treatment improved pancreatic islet cell senescence in aging mouse models, and critically, circulating MOTS-c levels are measurably lower in type 2 diabetes patients compared with healthy age-matched controls — suggesting a biomarker association.
• Glucose metabolism in diabetes (June 2025). A Frontiers in Physiology article examined how MOTS-c restores mitochondrial respiration and insulin-stimulated glucose uptake in type 2 diabetic heart and skeletal muscle models.
• Hepatic steatosis. Multiple studies link MOTS-c to reduced liver fat accumulation, an effect mediated by improved insulin sensitivity and reduced hepatic lipogenesis.

Regulatory status in 2026

MOTS-c is not FDA-approved. However, on July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8–6 to recommend MOTS-c for inclusion in the 503A bulk-drug-substances list — a non-binding recommendation. The FDA has not yet formally adopted this vote, and the final decision remains pending.

MOTS-c remains accessible exclusively as a research reagent for laboratory study and is not authorized for human or animal consumption outside of clinical trial settings.

MOTS-c research compound

We supply MOTS-c to the research community — HPLC-tested to 99% purity, with certificates of analysis on every batch, shipped from the USA, strictly for in-vitro laboratory use:

View MOTS-c (research grade)   Browse all research compounds

Sources & further reading

• MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner — PubMed (2026)
• Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes — PMC (2025)
• Mitochondrial-Derived Peptide MOTS-c, Diabetes, and Aging-Related Diseases — Diabetes & Metabolism Journal (2025)
• U.S. FDA — July 23–24, 2026 Meeting of the Pharmacy Compounding Advisory Committee

Universe Peptide publishes research-focused education for the scientific community. Products are for laboratory research only. See more in our News & research updates.